Boston An independent LDT provider


The principal task of Immunovia’s Investor Relations is to provide investors and the capital market with accurate, relevant and timely information that facilitates an understanding of the operations of Immunovia AB.

Contact Investor Relations for details:

Patrik Dahlen, CEO Immunovia


Tel: +46 73 376 76 64

You are also welcome to ask your question or make your request by: